aTen Therapeutics Ltd

📍 EDINBURGH, United Kingdom👥 4 employees💰 Last funded Dec 2015
Biotechnology🌐 atentherapeutics.com
Website LinkedIn
We are an innovative Scottish biotechnology company developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives. aTen Therapeutics Ltd (registered in Scotland no 547221) is a wholly-owned subsidiary of OncoBioPharm Limited (registered in Scotland 29/7/05 no. SC288225).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in aTen Therapeutics Ltd?
aTen Therapeutics Ltd has 1 investors on record on gritt.io.
When did aTen Therapeutics Ltd last raise funding?
The most recent investment in aTen Therapeutics Ltd recorded on gritt.io was in December 2015.
What industry is aTen Therapeutics Ltd in?
aTen Therapeutics Ltd operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is aTen Therapeutics Ltd based?
aTen Therapeutics Ltd is headquartered in EDINBURGH, United Kingdom.